These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28390397)

  • 1. Modelling the therapeutic dose range of single low dose primaquine to reduce malaria transmission through age-based dosing.
    Hayes DJ; Banda CG; Chipasula-Teleka A; Terlouw DJ
    BMC Infect Dis; 2017 Apr; 17(1):254. PubMed ID: 28390397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.
    Taylor WR; Naw HK; Maitland K; Williams TN; Kapulu M; D'Alessandro U; Berkley JA; Bejon P; Okebe J; Achan J; Amambua AN; Affara M; Nwakanma D; van Geertruyden JP; Mavoko M; Lutumba P; Matangila J; Brasseur P; Piola P; Randremanana R; Lasry E; Fanello C; Onyamboko M; Schramm B; Yah Z; Jones J; Fairhurst RM; Diakite M; Malenga G; Molyneux M; Rwagacondo C; Obonyo C; Gadisa E; Aseffa A; Loolpapit M; Henry MC; Dorsey G; John C; Sirima SB; Barnes KI; Kremsner P; Day NP; White NJ; Mukaka M
    BMC Med; 2018 Jan; 16(1):11. PubMed ID: 29347975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.
    Leang R; Khu NH; Mukaka M; Debackere M; Tripura R; Kheang ST; Chy S; Kak N; Buchy P; Tarantola A; Menard D; Roca-Felterer A; Fairhurst RM; Kheng S; Muth S; Ngak S; Dondorp AM; White NJ; Taylor WR
    BMC Med; 2016 Oct; 14(1):171. PubMed ID: 27784313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
    Taylor WR; Hoglund RM; Peerawaranun P; Nguyen TN; Hien TT; Tarantola A; von Seidlein L; Tripura R; Peto TJ; Dondorp AM; Landier J; H Nosten F; Smithuis F; Phommasone K; Mayxay M; Kheang ST; Say C; Neeraj K; Rithea L; Dysoley L; Kheng S; Muth S; Roca-Feltrer A; Debackere M; Fairhurst RM; Song N; Buchy P; Menard D; White NJ; Tarning J; Mukaka M
    Malar J; 2021 Sep; 20(1):366. PubMed ID: 34503519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doses of primaquine administered to children with
    Vieira MVDF; Matos Lopes TR; Mello AGNC; de Sena LWP; Commons RJ; Vieira JLF
    Pathog Glob Health; 2020 Oct; 114(7):388-392. PubMed ID: 32705964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa.
    Chen I; Poirot E; Newman M; Kandula D; Shah R; Hwang J; Cohen JM; Gosling R; Rooney L
    Malar J; 2015 May; 14():204. PubMed ID: 25971688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
    Morris U; Msellem MI; Mkali H; Islam A; Aydin-Schmidt B; Jovel I; Shija SJ; Khamis M; Ali SM; Hodzic L; Magnusson E; Poirot E; Bennett A; Sachs MC; Tarning J; Mårtensson A; Ali AS; Björkman A
    BMC Med; 2018 Dec; 16(1):215. PubMed ID: 30526588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?
    Chen IT; Gosling RD
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):681-6. PubMed ID: 25118908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinventing primaquine for endemic malaria.
    Baird JK
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):439-44. PubMed ID: 22998791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.
    Moore BR; Salman S; Benjamin J; Page-Sharp M; Robinson LJ; Waita E; Batty KT; Siba P; Mueller I; Davis TM; Betuela I
    Antimicrob Agents Chemother; 2014; 58(1):432-9. PubMed ID: 24189254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
    Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
    Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing regional weight-for-age growth references for malaria-endemic countries to optimize age-based dosing of antimalarials.
    Hayes DJ; van Buuren S; ter Kuile FO; Stasinopoulos DM; Rigby RA; Terlouw DJ
    Bull World Health Organ; 2015 Feb; 93(2):74-83. PubMed ID: 25883400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
    Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
    Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, Weight, and
    Gonçalves BP; Pett H; Tiono AB; Murry D; Sirima SB; Niemi M; Bousema T; Drakeley C; Ter Heine R
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.
    Stuckey EM; Miller JM; Littrell M; Chitnis N; Steketee R
    Malar J; 2016 Mar; 15():148. PubMed ID: 26957364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study evaluating the efficacy of a single, 45-mg dose of primaquine, as a gametocytocidal agent, in patients with Plasmodium falciparum malaria in Mumbai, India.
    Kamtekar KD; Gogtay NJ; Dalvi SS; Karnad DR; Chogle AR; Aigal U; Kshirsagar NA
    Ann Trop Med Parasitol; 2004 Jul; 98(5):453-8. PubMed ID: 15257794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for short course primaquine in Africa to interrupt malaria transmission.
    Eziefula AC; Gosling R; Hwang J; Hsiang MS; Bousema T; von Seidlein L; Drakeley C;
    Malar J; 2012 Oct; 11():360. PubMed ID: 23130957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.